Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track…
| Price | $76.71 |
|---|---|
| Market cap | $2.22B |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Exchange | NYSE |
| 52-week range | 38.91-147.03 |
| Beta | 0.7 |
Explore INSP's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.